HighTower Advisors LLC Makes New $638,000 Investment in LifeVantage Co. (NASDAQ:LFVN)

HighTower Advisors LLC bought a new stake in LifeVantage Co. (NASDAQ:LFVNFree Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 52,743 shares of the company’s stock, valued at approximately $638,000.

Several other hedge funds have also made changes to their positions in the company. Capital Management Corp VA purchased a new stake in shares of LifeVantage during the 3rd quarter valued at approximately $5,073,000. Renaissance Technologies LLC increased its stake in LifeVantage by 2.1% during the second quarter. Renaissance Technologies LLC now owns 855,118 shares of the company’s stock worth $5,490,000 after acquiring an additional 17,300 shares during the last quarter. Hantz Financial Services Inc. purchased a new stake in LifeVantage in the second quarter valued at $91,000. Finally, Ritholtz Wealth Management lifted its stake in shares of LifeVantage by 62.0% in the 3rd quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock valued at $346,000 after purchasing an additional 10,974 shares during the last quarter. Hedge funds and other institutional investors own 35.32% of the company’s stock.

Analyst Ratings Changes

Separately, Lake Street Capital assumed coverage on LifeVantage in a research report on Thursday. They set a “buy” rating and a $26.00 price objective for the company.

View Our Latest Stock Report on LFVN

LifeVantage Price Performance

Shares of LFVN opened at $17.73 on Friday. The firm has a 50-day simple moving average of $13.88 and a two-hundred day simple moving average of $10.24. LifeVantage Co. has a 1-year low of $5.22 and a 1-year high of $18.41. The stock has a market cap of $222.07 million, a PE ratio of 55.41 and a beta of 0.87.

LifeVantage (NASDAQ:LFVNGet Free Report) last posted its earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%. The firm had revenue of $47.21 million during the quarter.

LifeVantage Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Monday, December 2nd were paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.90%. The ex-dividend date was Monday, December 2nd. LifeVantage’s payout ratio is 50.00%.

About LifeVantage

(Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Recommended Stories

Want to see what other hedge funds are holding LFVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeVantage Co. (NASDAQ:LFVNFree Report).

Institutional Ownership by Quarter for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.